Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. Journal of Thrombosis and Haemostasis. October 2006, 4 (10): 2103–2114. PMID 16889557. S2CID 23875096. doi:10.1111/j.1538-7836.2006.02146.x.
Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, et al. Acquired von Willebrand syndrome in aortic stenosis. The New England Journal of Medicine. July 2003, 349 (4): 343–349. PMID 12878741. doi:10.1056/NEJMoa022831.
Denorme F, De Meyer SF. The VWF-GPIb axis in ischaemic stroke: lessons from animal models. Thrombosis and Haemostasis. September 2016, 116 (4): 597–604. PMID 27029413. S2CID 4964177. doi:10.1160/TH16-01-0036.
Roldán V, Marín F, Muiña B, Torregrosa JM, Hernández-Romero D, Valdés M, et al. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. Journal of the American College of Cardiology. June 2011, 57 (25): 2496–2504. PMID 21497043. doi:10.1016/j.jacc.2010.12.033.
Pareti FI, Fujimura Y, Dent JA, Holland LZ, Zimmerman TS, Ruggeri ZM. Isolation and characterization of a collagen binding domain in human von Willebrand factor. The Journal of Biological Chemistry. November 1986, 261 (32): 15310–15315. PMID 3490481. doi:10.1016/S0021-9258(18)66869-3.
Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. Journal of Thrombosis and Haemostasis. October 2006, 4 (10): 2103–2114. PMID 16889557. S2CID 23875096. doi:10.1111/j.1538-7836.2006.02146.x.
Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, et al. Acquired von Willebrand syndrome in aortic stenosis. The New England Journal of Medicine. July 2003, 349 (4): 343–349. PMID 12878741. doi:10.1056/NEJMoa022831.
Denorme F, De Meyer SF. The VWF-GPIb axis in ischaemic stroke: lessons from animal models. Thrombosis and Haemostasis. September 2016, 116 (4): 597–604. PMID 27029413. S2CID 4964177. doi:10.1160/TH16-01-0036.
Roldán V, Marín F, Muiña B, Torregrosa JM, Hernández-Romero D, Valdés M, et al. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. Journal of the American College of Cardiology. June 2011, 57 (25): 2496–2504. PMID 21497043. doi:10.1016/j.jacc.2010.12.033.
Pareti FI, Fujimura Y, Dent JA, Holland LZ, Zimmerman TS, Ruggeri ZM. Isolation and characterization of a collagen binding domain in human von Willebrand factor. The Journal of Biological Chemistry. November 1986, 261 (32): 15310–15315. PMID 3490481. doi:10.1016/S0021-9258(18)66869-3.
Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. Journal of Thrombosis and Haemostasis. October 2006, 4 (10): 2103–2114. PMID 16889557. S2CID 23875096. doi:10.1111/j.1538-7836.2006.02146.x.
Denorme F, De Meyer SF. The VWF-GPIb axis in ischaemic stroke: lessons from animal models. Thrombosis and Haemostasis. September 2016, 116 (4): 597–604. PMID 27029413. S2CID 4964177. doi:10.1160/TH16-01-0036.